|
|
|
| Effect of Salmeterol Combined with Montelukast Sodium on the Lung Function and serum NO ET IFN-γ Levels of Children with Bronchial Asthma |
| PANG Jun, HUANG Rui, WANG Yuan, et al |
| Mianyang No.404 Hospital / the Second Affiliated Hospital of North Sichuan Medical College, Sichuan Mianyang 621000, China |
|
|
|
|
Abstract Objective: To study the effect of salmeterol combined with montelukast sodium on the lung function, Carbon monoxide(NO), Endothelin (ET), interferon-γ(IFN-γ) levels of children with bronchial asthma. Methods: 120 patients of bronchial asthma who were treated from April 2014 to April 2015 in our hospital were selected as research objects. According to draw method,those patients were divided into salmeterol group 40 cases, 40 cases of the combined group and montelukast group in 40 cases. three groups were given routine treatment of bronchial antispasmodic, oxygen inhalation, antibiotics and glucocorticoids, aminophylline Sustained-release Tablets was given according to the situation of children. The Salmeterol group was treated with routine treatment combined with salmeterol. while the combined group was treated with Montelukast sodium combined with Salmeterol. montelukast sodium group was treated with montelukast sodium.Then the clinical effect, wheezing, wheezing, wet rales disappeared time, FEV1, FEV1/FVC, PEF, NO, ET, IFN- gamma levels were compared between two groups. Results: The total effective rate of combined group was significantly higher than that of the control group (P＜0.05); the disappearance time of wheezing, wheezing and rales were significantly shorter than those of the salmeterol and montelukast sodium group(P<0.05); FEV1,FEV1/FVC,PEF were significantly higher than those of the salmeterol and montelukast sodium group (P＜0.05); serum NO, ET levels were significantly lower than those of the salmeterol and montelukast sodium group(P＜0.05), IFN-γ was significantly higher than that of the salmeterol and montelukast sodium group(P＜0.05). Conclusion: The combination of two drugs in the treatment of children with bronchial asthma is superior to the treatment of Shah Mette Lo or montelukast sodium, which can significantly improve the lung function of children. It may be related to the effective regulation of serum NO, ET and IFN- gamma levels.
|
|
|
|
|
|
[1] 吴峰,张笃飞.孟鲁司特钠改善小儿支气管哮喘患者肺功能和气道炎症的临床疗效与安全性[J].中国现代医生,2015,53(11):105~108.
[2] 廖建平.孟鲁司特钠联合沙美特罗替卡松治疗小儿支气管哮喘的临床疗效观察[J].基层医学论坛,2015,19(25):3481~3482.
[3] 张照中,李彦青.布地奈德与孟鲁司特钠联用治疗小儿支气管哮喘的临床疗效研究[J].中国卫生标准管理,2015,6(28):118~119.
[4] 梁义国.浅谈小儿支气管哮喘治疗的研究进展[J].现代诊断与治疗,2015,26(3):695~697.
[5] 郝建成.孟鲁司特钠联合布地奈德治疗小儿支气管哮喘临床疗效及改善肺功能的作用研究[J].医药论坛杂志,2013,34(03):44~46.
[6] 吴玲玲.布地奈德吸入联合孟鲁司特钠对小儿哮喘疗效及炎症因子的影响[J].中国妇幼保健,2017,32(01):191~194.
[7] 王匀,黄伟鹏,梁煜,等.孟鲁司特钠片辅助治疗支气管哮喘急性发作的可行性及安全性研究[J].中国医药科学,2016,6(07):95~98.
[8] 邢学伟,葛昌玲.沙美特罗联合孟鲁司特钠对小儿支气管哮喘肺功能及TNF-α、NO、ET表达的影响[J].广西医科大学学报,2017,3408:1185~1188. |
|
|
|
2018, Vol. 24 
